LONGEVITY MEDICAL INSTITUTE
Live / Registered — Registered (as of 19 Aug 2025)
What this means for you
Registered since 19 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98721065
- Registration number
- 7908729
- Mark type
- Stylized text
- Filed
- 28 Aug 2024
- Registered
- 19 Aug 2025
- Attorney of record
- Eric Lamb
Goods and services
- Class 044 — Medical, beauty and agricultural services: Stem cell therapy services; Medical testing for diagnostic or treatment purposes; Healthcare and medical tourism services, namely, establishing and maintaining healthcare provider facilities in other countries for the provision of healthcare services; Medical clinic providing hormone therapy, including, bioidentical hormone replacement, human growth hormone therapy, and natural hormone therapy; Consulting services in the field of hormone replacement therapy; Regenerative medicine services; Medical imaging services; Skin treatment, namely, the injection of dermal fillers to reduce the appearance of facial lines and wrinkles; Injectable botulinum toxin treatment services for medical purposes; Injectable botulinum toxin treatment services for cosmetic purposes; Providing laser therapy for treating medical conditions
Owner
- Longevity Medical Institute, LLC, Houston, TX, US
- Longevity Medical Institute, LLC, Houston, TX, US
Prosecution history
- 19 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Aug 2025 — REGISTERED-SUPPLEMENTAL REGISTER
- 14 Jul 2025 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 14 Jul 2025 — EXAMINER'S AMENDMENT ENTERED
- 14 Jul 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 Jul 2025 — EXAMINERS AMENDMENT E-MAILED
- 14 Jul 2025 — EXAMINERS AMENDMENT -WRITTEN
- 27 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Apr 2025 — NON-FINAL ACTION E-MAILED
- 15 Apr 2025 — NON-FINAL ACTION WRITTEN
- 15 Apr 2025 — USE AMENDMENT ACCEPTED
- 11 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED